NO833942L - Beta-karboliner, fremgangsmaate til deres fremstilling og farmasoeytiske preparater som inneholder dem - Google Patents
Beta-karboliner, fremgangsmaate til deres fremstilling og farmasoeytiske preparater som inneholder demInfo
- Publication number
- NO833942L NO833942L NO833942A NO833942A NO833942L NO 833942 L NO833942 L NO 833942L NO 833942 A NO833942 A NO 833942A NO 833942 A NO833942 A NO 833942A NO 833942 L NO833942 L NO 833942L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- pharmaceutical preparations
- preparations containing
- carbolines
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000005923 long-lasting effect Effects 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- AIFRHYZBTHREPW-UHFFFAOYSA-N β-carboline Chemical class N1=CC=C2C3=CC=CC=C3NC2=C1 AIFRHYZBTHREPW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823240514 DE3240514A1 (de) | 1982-10-29 | 1982-10-29 | Ss-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO833942L true NO833942L (no) | 1984-04-30 |
Family
ID=6177153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO833942A NO833942L (no) | 1982-10-29 | 1983-10-28 | Beta-karboliner, fremgangsmaate til deres fremstilling og farmasoeytiske preparater som inneholder dem |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4731358A (fi) |
| EP (1) | EP0110814B1 (fi) |
| JP (1) | JPH0633260B2 (fi) |
| AT (1) | ATE48602T1 (fi) |
| AU (1) | AU568513B2 (fi) |
| CA (1) | CA1260475A (fi) |
| DD (1) | DD213217A5 (fi) |
| DE (2) | DE3240514A1 (fi) |
| DK (1) | DK495683A (fi) |
| ES (1) | ES526896A0 (fi) |
| FI (1) | FI833918A (fi) |
| GR (1) | GR79637B (fi) |
| HU (1) | HU198208B (fi) |
| IE (1) | IE56155B1 (fi) |
| IL (1) | IL70077A0 (fi) |
| NO (1) | NO833942L (fi) |
| NZ (1) | NZ205949A (fi) |
| ZA (1) | ZA838072B (fi) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3240511A1 (de) * | 1982-10-29 | 1984-05-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur herstellung von ss-carbolinderivaten |
| DE3322895A1 (de) * | 1983-06-23 | 1985-01-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue ss-carboline, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel (s) |
| US4631149A (en) * | 1983-07-25 | 1986-12-23 | University Of Illinois | Antiviral eudistomins from a marine tunicate |
| DE3504045A1 (de) * | 1985-02-04 | 1986-08-07 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur herstellung von ss-carbolinen durch dehydrierung |
| DE3535927A1 (de) * | 1985-10-04 | 1987-04-09 | Schering Ag | 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel |
| US4952584A (en) * | 1986-01-11 | 1990-08-28 | Beecham Group P.L.C. | 9H-pyrido[2,B-8]indole-3-carboxylic acid ester compounds having useful pharmaceutical activity |
| US4789676A (en) * | 1986-03-05 | 1988-12-06 | Merrell Dow Pharmaceuticals Inc. | Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives, usefull as anxiolytic agents |
| US5223509A (en) * | 1987-08-17 | 1993-06-29 | Merck & Co., Inc. | β-carbolines as cholecystokinin and gastrin antagonists |
| EP0304223A3 (en) * | 1987-08-17 | 1990-10-24 | Merck & Co. Inc. | Beta-carbolines as cholecy-stokinin and gastrin antagonist |
| AU619203B2 (en) * | 1987-08-28 | 1992-01-23 | Schering Aktiengesellschaft | Isoxazole-beta-carboline derivatives |
| DE4029389A1 (de) * | 1990-09-13 | 1992-03-26 | Schering Ag | Verfahren zur herstellung von (beta)-carbolin-derivaten |
| US5350750A (en) * | 1991-04-27 | 1994-09-27 | Schering Aktiengesellschaft | β-carboline-3-hydroxyalkylcarboxylic acid ester derivatives, process for their production and their use in pharmaceutical agents |
| HUT75522A (en) * | 1994-03-11 | 1997-05-28 | Lilly Co Eli | Indole-, pyrido-indole-, indolo-quinoline- and benzo-pyrido-indole-derivatives, method for treating 5ht2b receptor related conditions, pharmaceutical compositions containing them |
| WO1998006719A1 (en) * | 1996-08-09 | 1998-02-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | 4-substituted beta-carbolines as immunomodulators |
| AU3741801A (en) | 2000-03-15 | 2001-09-24 | Aventis Pharma Gmbh | Substituted beta-carbolines with ikb-kinase inhibiting activity |
| EP1134221A1 (en) * | 2000-03-15 | 2001-09-19 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines as lkB kinase inhibitors |
| EP1209158A1 (en) * | 2000-11-18 | 2002-05-29 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines |
| US20030045541A1 (en) * | 2001-07-23 | 2003-03-06 | Christopher Bruckner | GABA-Receptor modulators with NMDA-Antagonistic activity |
| DE102007009264A1 (de) * | 2007-02-26 | 2008-08-28 | Ellneuroxx Ltd. | 9-Alkyl-ß-Carboline zur Behandlung von neurodegenerativen Erkrankungen |
| AU2010338669A1 (en) | 2009-12-28 | 2012-06-21 | Audiocure Pharma Gmbh | Beta-carbolines for use in the treatment of hearing loss and vertigo |
| CN102146080B (zh) * | 2010-02-10 | 2013-01-30 | 新疆华世丹药业股份有限公司 | β-咔啉碱衍生物类化合物及其应用 |
| EP2455378A1 (en) | 2010-11-03 | 2012-05-23 | Philip Morris Products S.A. | Carbazole and carboline derivatives, and preparation and therapeutic applications thereof |
| CN102093347A (zh) * | 2010-12-17 | 2011-06-15 | 中国药科大学 | 1,3,6-三取代-β-咔啉类细胞周期蛋白依赖性激酶2抑制剂及其用途 |
| US11117893B2 (en) * | 2018-09-24 | 2021-09-14 | Union University | Methods for preparation of substituted pyridines and related novel compounds |
| WO2020072675A1 (en) | 2018-10-02 | 2020-04-09 | Northwestern University | Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2c (5-ht2c) |
| CN115335046A (zh) * | 2020-03-25 | 2022-11-11 | 思研（Sri）国际顾问与咨询公司 | 脂肪氧合酶抑制剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4730718U (fi) * | 1971-04-27 | 1972-12-07 | ||
| NZ194747A (en) * | 1979-08-29 | 1988-11-29 | Schering Ag | 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives |
| JPS57123180A (en) * | 1980-12-17 | 1982-07-31 | Schering Ag | 3-substituted beta-carboline, manufacture and psychotropic drug containing same |
| DE3240511A1 (de) * | 1982-10-29 | 1984-05-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur herstellung von ss-carbolinderivaten |
| DE3322895A1 (de) * | 1983-06-23 | 1985-01-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue ss-carboline, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel (s) |
| JPH07230718A (ja) * | 1994-02-17 | 1995-08-29 | Hitachi Plant Eng & Constr Co Ltd | クリーンルーム用プレハブ分岐付ケーブル |
-
1982
- 1982-10-29 DE DE19823240514 patent/DE3240514A1/de not_active Withdrawn
-
1983
- 1983-10-13 NZ NZ205949A patent/NZ205949A/en unknown
- 1983-10-20 JP JP58195407A patent/JPH0633260B2/ja not_active Expired - Lifetime
- 1983-10-26 FI FI833918A patent/FI833918A/fi not_active Application Discontinuation
- 1983-10-26 GR GR72789A patent/GR79637B/el unknown
- 1983-10-27 DD DD83256042A patent/DD213217A5/de unknown
- 1983-10-27 AT AT83730103T patent/ATE48602T1/de not_active IP Right Cessation
- 1983-10-27 DE DE8383730103T patent/DE3380958D1/de not_active Expired - Lifetime
- 1983-10-27 EP EP83730103A patent/EP0110814B1/de not_active Expired
- 1983-10-28 ES ES526896A patent/ES526896A0/es active Granted
- 1983-10-28 CA CA000439951A patent/CA1260475A/en not_active Expired
- 1983-10-28 ZA ZA838072A patent/ZA838072B/xx unknown
- 1983-10-28 AU AU20694/83A patent/AU568513B2/en not_active Ceased
- 1983-10-28 IE IE2529/83A patent/IE56155B1/en not_active IP Right Cessation
- 1983-10-28 HU HU833711A patent/HU198208B/hu not_active IP Right Cessation
- 1983-10-28 DK DK495683A patent/DK495683A/da not_active Application Discontinuation
- 1983-10-28 NO NO833942A patent/NO833942L/no unknown
- 1983-10-28 IL IL70077A patent/IL70077A0/xx unknown
-
1986
- 1986-09-02 US US06/902,855 patent/US4731358A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GR79637B (fi) | 1984-10-31 |
| ES8406477A1 (es) | 1984-08-01 |
| DD213217A5 (de) | 1984-09-05 |
| DE3380958D1 (de) | 1990-01-18 |
| IE56155B1 (en) | 1991-05-08 |
| HU198208B (en) | 1989-08-28 |
| EP0110814A2 (de) | 1984-06-13 |
| AU568513B2 (en) | 1988-01-07 |
| FI833918A0 (fi) | 1983-10-26 |
| EP0110814A3 (en) | 1985-07-24 |
| US4731358A (en) | 1988-03-15 |
| IL70077A0 (en) | 1984-01-31 |
| ES526896A0 (es) | 1984-08-01 |
| JPS5989678A (ja) | 1984-05-23 |
| DE3240514A1 (de) | 1984-05-03 |
| NZ205949A (en) | 1987-03-31 |
| AU2069483A (en) | 1984-05-03 |
| ATE48602T1 (de) | 1989-12-15 |
| IE832529L (en) | 1984-04-29 |
| ZA838072B (en) | 1984-06-27 |
| JPH0633260B2 (ja) | 1994-05-02 |
| CA1260475A (en) | 1989-09-26 |
| FI833918A (fi) | 1984-04-30 |
| DK495683A (da) | 1984-04-30 |
| DK495683D0 (da) | 1983-10-28 |
| EP0110814B1 (de) | 1989-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO833942L (no) | Beta-karboliner, fremgangsmaate til deres fremstilling og farmasoeytiske preparater som inneholder dem | |
| ES2053524T3 (es) | Un procedimiento para preparar un compuesto quimico. | |
| DK0528734T3 (da) | Thiaxolidin-2,4-dionderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| ZA895090B (en) | Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds | |
| DK0530087T3 (da) | Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DK93685D0 (da) | Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser | |
| NO813109L (no) | Ammoniometylforbindelser, fremgangsmaate til ders fremstilling, farmasoeytiske preparater som inneholder disse forbindelser og anvendelsen av disse | |
| IS1565B (is) | Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar | |
| DK400681A (da) | Isoquinolinderivater fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse forbindelser og deres anvendelse | |
| DK254386A (da) | Pyridinderivater, fremgangsmaade til fremstilling heraf og praeparaterindeholdende disse forbindelser | |
| ES8305684A1 (es) | Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas. | |
| DK542781A (da) | Tricycliske cytosinderivater til anvendelse som laegemidler samt fremgangsmaade til fremstilling heraf | |
| NO883074L (no) | Fremgangsmaate til fremstilling av 3-desmetyl-4-fluor-mevalonsyrederivater. | |
| FI811672L (fi) | Nya substituerade 3-fenoxi-1-alkoxi-karbonyl-alkylamino-propanol-2-foereningar med beta-receptor haemmande verkan | |
| AU6216586A (en) | New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them | |
| NO874355L (no) | Fremgangsmaate for fremstilling av glycolipid som inneholder n-glycolylneuraminsyre. | |
| SE8302751L (sv) | 2(1h)-pyridinonderivat, deras framstellning och farmaceutiska beredningar som innehaller dem | |
| DK119188A (da) | Substituerede pyridin-2,4-dicarboxylsyrederivater, fremgangsmaader til deres fremstilling samt laegemiddel indeholdende forbindelserne | |
| DK450086A (da) | 12- og 13-bromergolinderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse | |
| IL67400A (en) | Octahydro-3,7a-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them | |
| DK572189A (da) | Substituerede adeninderivater og farmaceutisk praeparat indeholdende dem | |
| NO820618L (no) | 7-acylamido-3-cefem-4-karboksylsyreforbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse forbindelser og anvendelse av sistnevnte | |
| SU993624A1 (ru) | 2,3-дифенилтиазоло (3',2',2,3)(1,2,4)триазино (6,5-в) индол, обладающий противовоспалительной активностью | |
| SU976666A1 (ru) | 2,3-дифенилтиазоло /3',2',2,3/-1,2,4-триазино-/5,6-b/ индол, обладающий противовоспалительной активностью | |
| ATE75613T1 (de) | 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen. |